MSB Trading halt 16/12/20 PRICE SENSITIVE download Created with Sketch. 155.18KB Share MSB Pause in Trading 16/12/20 PRICE SENSITIVE download Created with Sketch. 116.28KB Share MSB Mesoblast Phase 3 Chronic Heart Failure Results 15/12/20 PRICE SENSITIVE download Created with Sketch. 130.08KB Share MSB Mesoblast Corporate Update Webcast 15/12/20 download Created with Sketch. 105.09KB Share MSB Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD 07/12/20 download Created with Sketch. 146.6KB Share MSB Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS 02/12/20 PRICE SENSITIVE download Created with Sketch. 116.21KB Share MSB Appendix 2A 27/11/20 download Created with Sketch. 167.16KB Share MSB Results of Meeting 24/11/20 download Created with Sketch. 208.38KB Share MSB CEO Presentation to 2020 Annual General Meeting 24/11/20 download Created with Sketch. 1.7MB Share MSB Mesoblast Chairman Message to 2020 AGM 24/11/20 download Created with Sketch. 113.7KB Share MSB Novartis and Mesoblast Remestemcel-L Collaboration 20/11/20 PRICE SENSITIVE download Created with Sketch. 147.21KB Share MSB First Quarter Results Presentation 20/11/20 PRICE SENSITIVE download Created with Sketch. 2.18MB Share MSB MSB Q1 Financial Results and Operational Highlights 20/11/20 PRICE SENSITIVE download Created with Sketch. 271.6KB Share MSB First Quarter Financial Results on Form 6-K 20/11/20 PRICE SENSITIVE download Created with Sketch. 590.73KB Share MSB Mesoblast Corporate Update and Financial Results Webcast 20/11/20 download Created with Sketch. 81.67KB Share MSB DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial 11/11/20 PRICE SENSITIVE download Created with Sketch. 117.63KB Share MSB COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C 29/10/20 PRICE SENSITIVE download Created with Sketch. 192.37KB Share MSB Annual Report to shareholders 26/10/20 download Created with Sketch. 3.05MB Share MSB Notice of Annual General Meeting and Proxy Form 26/10/20 download Created with Sketch. 357.21KB Share MSB Appendix 4G and Corporate Governance Statement 26/10/20 download Created with Sketch. 202.52KB Share MSB Remestemcel Controlled Study in Crohns & Ulcerative Colitis 22/10/20 download Created with Sketch. 126.07KB Share MSB Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment 13/10/20 download Created with Sketch. 115.52KB Share MSB Update on BLA for Graft Versus Host Disease 02/10/20 PRICE SENSITIVE download Created with Sketch. 93.31KB Share MSB Trading Halt 01/10/20 PRICE SENSITIVE download Created with Sketch. 153.58KB Share MSB MSB Wins Fierce Biotech Innovation Award for Remestemcel-L 15/09/20 PRICE SENSITIVE download Created with Sketch. 109.05KB Share MSB Appendix 2A 10/09/20 download Created with Sketch. 167.69KB Share MSB Change in substantial holding 07/09/20 download Created with Sketch. 258.94KB Share MSB DSMB Recommends Continuation of Phase 3 COVID-19 Trial 04/09/20 PRICE SENSITIVE download Created with Sketch. 110.61KB Share MSB Ethics Approval to Treat COVID-19 Patients in Australia 02/09/20 download Created with Sketch. 112.63KB Share MSB Change in substantial holding 02/09/20 download Created with Sketch. 258.72KB Share MSB MSB Annual Financial Results and Operational Progress 27/08/20 PRICE SENSITIVE download Created with Sketch. 270.6KB Share MSB Annual Financial Results Presentation 27/08/20 download Created with Sketch. 2.26MB Share MSB Preliminary Final Report including Appendix 4E 27/08/20 PRICE SENSITIVE download Created with Sketch. 2.48MB Share MSB Mesoblast 2020 Full Year Financial Results Webcast 26/08/20 download Created with Sketch. 57.31KB Share MSB Change in substantial holding 24/08/20 download Created with Sketch. 271.29KB Share MSB Change in substantial holding 21/08/20 download Created with Sketch. 247.46KB Share MSB Appendix 2A and Appendix 3G 20/08/20 download Created with Sketch. 249.55KB Share MSB ODAC Votes in Favor of Remestemcel-L for GvHD 14/08/20 PRICE SENSITIVE download Created with Sketch. 117.69KB Share MSB Trading Halt 13/08/20 PRICE SENSITIVE download Created with Sketch. 155.11KB Share MSB Change in substantial holding - Amendment 12/08/20 download Created with Sketch. 284.13KB Share MSB Change in substantial holding - Amendment 12/08/20 download Created with Sketch. 265.5KB Share MSB Update on Scheduled FDA Advisory Committee Meeting 11/08/20 PRICE SENSITIVE download Created with Sketch. 109.23KB Share MSB Change in substantial holding 10/08/20 download Created with Sketch. 230.03KB Share MSB Change in substantial holding 07/08/20 download Created with Sketch. 85.81KB Share MSB Appendix 2A 06/08/20 download Created with Sketch. 163.17KB Share MSB Proposed issue of Securities - MSB 06/08/20 download Created with Sketch. 24.9KB Share MSB COVID-19/GVHD Update, Quarterly Report and Appendix 4C 30/07/20 PRICE SENSITIVE download Created with Sketch. 230.46KB Share MSB Mesoblast Expands Executive Leadership Team 24/07/20 download Created with Sketch. 131.59KB Share MSB FDA Advisory Committee Sets Review Date for Remestemcel-L 21/07/20 PRICE SENSITIVE download Created with Sketch. 108.87KB Share MSB Appendix 3B, 2A with prospectus- Kentgrove Capital 07/07/20 download Created with Sketch. 809.43KB Share MSB EAP for Remestemcel-L in Children with MIS-C due to COVID-19 06/07/20 download Created with Sketch. 108.82KB Share MSB Appendix 2A 30/06/20 download Created with Sketch. 163.22KB Share MSB Appendix 3G with 3Ys 24/06/20 download Created with Sketch. 267.14KB Share MSB Appendix 2A 16/06/20 download Created with Sketch. 166.58KB Share MSB S&P DJI Announces June 2020 Quarterly Rebalance 12/06/20 PRICE SENSITIVE download Created with Sketch. 223.16KB Share MSB Appendix 2A 01/06/20 download Created with Sketch. 164.04KB Share MSB Remestemcel-L Improves Outcomes in Inflammatory Lung Disease 01/06/20 PRICE SENSITIVE download Created with Sketch. 116.33KB Share MSB MSB Reports Q3 Financial Results and Operational Highlights 28/05/20 PRICE SENSITIVE download Created with Sketch. 281.8KB Share MSB Third Quarter Results Presentation 28/05/20 download Created with Sketch. 1.72MB Share MSB Third Quarter Financial Results on Form 6-K 28/05/20 PRICE SENSITIVE download Created with Sketch. 614.49KB Share MSB Change in substantial holding 27/05/20 download Created with Sketch. 250.69KB Share MSB 3 Articles on RYONCIL GvHD Trial Results Published in BBMT 25/05/20 download Created with Sketch. 124.22KB Share MSB Change in substantial holding 19/05/20 download Created with Sketch. 159.15KB Share MSB Cleansing Notice 18/05/20 download Created with Sketch. 72.61KB Share MSB Appendix 2As 15/05/20 download Created with Sketch. 375.44KB Share MSB Proposed issue of Securities - MSB 13/05/20 download Created with Sketch. 27.78KB Share MSB MSB Completes Financing For Covid-19 ARDS Manufacturing 13/05/20 PRICE SENSITIVE download Created with Sketch. 144.68KB Share MSB Trading Halt 11/05/20 PRICE SENSITIVE download Created with Sketch. 170.3KB Share MSB First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS 06/05/20 download Created with Sketch. 128.22KB Share MSB Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment 30/04/20 PRICE SENSITIVE download Created with Sketch. 140.07KB Share MSB Appendix 4C - quarterly 29/04/20 PRICE SENSITIVE download Created with Sketch. 193.38KB Share MSB 83% Survival in COVID-19 ARDS Patients with Remestemcel-L 24/04/20 PRICE SENSITIVE download Created with Sketch. 144.87KB Share MSB Inflammatory Lung Disease Outcomes For Presentation at ISCT 17/04/20 download Created with Sketch. 116.14KB Share MSB US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial 09/04/20 PRICE SENSITIVE download Created with Sketch. 95.91KB Share MSB FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients 06/04/20 PRICE SENSITIVE download Created with Sketch. 89.95KB Share MSB FDA Accepts BLA for RYONCIL and Agrees to Priority Review 01/04/20 PRICE SENSITIVE download Created with Sketch. 92.3KB Share MSB Ischemic End Stage HF Outcomes at Virtual ACC Annual Meeting 30/03/20 download Created with Sketch. 94.18KB Share MSB Change of Director's Interest Notice 20/03/20 download Created with Sketch. 71.77KB Share MSB Appendix 2A 17/03/20 download Created with Sketch. 147.18KB Share MSB Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease 10/03/20 PRICE SENSITIVE download Created with Sketch. 98.41KB Share MSB Mesoblast Provides Half Year Results and Corporate Update 27/02/20 PRICE SENSITIVE download Created with Sketch. 223.76KB Share MSB Half Year Financial Results Presentation 27/02/20 download Created with Sketch. 1.46MB Share MSB Half Year Report and Accounts (including Appendix 4D) 27/02/20 PRICE SENSITIVE download Created with Sketch. 757.72KB Share MSB Mesoblast Half Year FY 2020 Financial Results Analyst Call 25/02/20 download Created with Sketch. 70.25KB Share MSB Ryoncil Results in Children with Acute GvHD Presented at TCT 24/02/20 download Created with Sketch. 146.94KB Share MSB Appendix 3G 21/02/20 download Created with Sketch. 131.61KB Share MSB Positive Outcomes Using Remestemcel-L in Chronic GVHD 20/02/20 download Created with Sketch. 94.61KB Share MSB Appendix 2A 07/02/20 download Created with Sketch. 165.97KB Share MSB Mesoblast Submits Completed BLA for Ryoncil to US FDA 03/02/20 PRICE SENSITIVE download Created with Sketch. 114.77KB Share MSB Appendix 4C - quarterly 29/01/20 PRICE SENSITIVE download Created with Sketch. 219.65KB Share MSB Appendix 2A 24/01/20 download Created with Sketch. 147.69KB Share MSB Biotech Showcase Presentation 15/01/20 download Created with Sketch. 2.05MB Share MSB MSB Presents Commercial Plans at 2020 Biotech Showcase 15/01/20 download Created with Sketch. 144.16KB Share MSB Appendix 2A 02/01/20 download Created with Sketch. 143.67KB Share MSB MSB Files GvHD Clinical Efficacy and Safety Data with US FDA 02/01/20 PRICE SENSITIVE download Created with Sketch. 128.07KB Share MSB DMC Completes Final Review of Phase 3 Heart Failure Trial 18/12/19 PRICE SENSITIVE download Created with Sketch. 119.18KB Share MSB CHF P3Trial Accrues Sufficient Primary EndPt Events(Correct) 17/12/19 PRICE SENSITIVE download Created with Sketch. 122.93KB Share MSB CHF P3 Trial Accrues Sufficient Primary Endpoint Events 17/12/19 PRICE SENSITIVE download Created with Sketch. 122.57KB Share MSB Ceasing to be a substantial holder 05/12/19 download Created with Sketch. 212.21KB Share MSB Change of Director's Interest Notice 05/12/19 download Created with Sketch. 70.89KB Share